US2002091440A1PendingUtilityA1

Drug delivery graft

Assignee: IMPRA INC A SUBSIDIARY OF C RPriority: Jan 20, 2000Filed: Jan 31, 2002Published: Jul 11, 2002
Est. expiryJan 20, 2020(expired)· nominal 20-yr term from priority
Inventors:Robert Calcote
A61L 31/048A61L 2300/416A61L 27/54A61L 2300/00A61L 27/16A61L 31/16A61F 2/06A61F 2250/0068
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An improved drug delivery graft comprises a drug delivery device coupled to an outer wall of a porous graft. An agent is conducted by the drug delivery device from a source to the outer wall of the graft where it is released to diffuse into the lumen of the graft through porous interstices of the outer wall.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A drug delivery graft, comprising: 
 a graft comprising a lumen defined by an outer wall, wherein the outer wall is characterized by a microstructure having nodes interconnected by fibrils; and    drug delivery means coupled to the outer wall for delivering a drug thereto, wherein the drug diffuses into the lumen through the outer wall.    
     
     
         2 . The drug delivery graft according to  claim 1 , further comprising a drug source coupled to the drug delivery means.  
     
     
         3 . The drug delivery graft according to  claim 1 , wherein the drug delivery means comprises a hollow tube.  
     
     
         4 . The drug delivery graft according to  claim 3 , wherein the hollow tube is arranged substantially parallel to a longitudinal axis of the graft.  
     
     
         5 . The drug delivery graft according to  claim 3 , wherein the hollow tube comprises a cutaway portion in communication with the outer wall.  
     
     
         6 . The drug delivery graft according to  claim 3 , wherein the hollow tube comprises perforations in communication with the outer wall.  
     
     
         7 . The drug delivery graft according to  claim 3 , wherein the hollow tube comprises a porous wall in communication with the outer wall.  
     
     
         8 . The drug delivery graft according to  claim 1 , wherein the graft comprises expanded polytetrafluoroethylene.  
     
     
         9 . The drug delivery graft according to  claim 1 , wherein the drug is selected from the group consisting of a growth factor, a growth factor inhibitor, growth factor receptor antagonist, a transcriptional repressor, a translational repressor, an antisense nucleic acid, a replication inhibitor, an anti-microtubule agent, an inhibitory antibody, an antibody directed against a growth factor, a bifunctional molecules comprising a growth factor and a cytotoxin, and a bifunctional molecule comprising an antibody and a cytotoxin.

Join the waitlist — get patent alerts

Track US2002091440A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.